Log in
Main Navigation
‹ Return to Hematopoietic stem cell transplant from blood or bone marrow (HSCT): Defibrotide sodium (Defitelio) approved for the treatment of hepatic veno-occlusive disease (VOD) in patients after HSCT
You must be logged in to post a comment.
Optional: Social Subscribe/Login
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply
You must be logged in to post a comment.
Optional: Social Subscribe/Login